RAPT Therapeutics, Inc. — Director's Dealing 2021

Apr 14, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RAPT Therapeutics, Inc. (RAPT)
CIK: 0001673772
Period of Report: 2021-04-09

Reporting Person: Robbins Wendye (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-04-09	Common Stock	P	26	$20.915	Acquired	4826	Direct
2021-04-09	Common Stock	P	79	$20.99	Acquired	4905	Direct
2021-04-09	Common Stock	P	21	$20.99	Acquired	4926	Direct
2021-04-09	Common Stock	P	100	$21	Acquired	5026	Direct
2021-04-09	Common Stock	P	74	$21.0662	Acquired	5100	Direct
2021-04-09	Common Stock	P	300	$21.2399	Acquired	5400	Direct
2021-04-09	Common Stock	P	300	$20.9542	Acquired	800	Indirect
2021-04-09	Common Stock	P	500	$21.0899	Acquired	1300	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	300	Indirect